Video by PCR via YouTube
Go to Source

Join Patrick Serruys and Ashok Seth in this #pcrlv 2024 roundtable as they dive into two key trials: the LANDMARK Trial, which compares the Indian Myval series to the Sapien and Evolut series, and the COMPARE TAVI Trial, which also pits Myval against Sapien.
They analyze one-year outcomes, discuss the design, sizes, and features of the valves, and highlight how the fitting index contributes to improving outcomes.
They also delve into the importance of commissural alignment and the long-term durability of these valves, alongside the promising results of the Myval Octapro THV.

Supported by Meril

More interviews on PCRonline: https://www.pcronline.com/Cases-resources-images/Resources/Educational-interviews

#transcatheter
#heartvalve
#selfexpandable
#fitting
#commissuralalignment

Go to Source